We dont currently handle insurance or prior authorizations for GLP-1 medications, but please check back soon
Being open with your practitioner is important
its what the GLP-1s lead to without intervention
Understanding your genetic predispositions, combined with comprehensive clinical evaluation, can support a more informed conversation with your healthcare provider about semaglutide eligibility and whether alternative GLP-1 options or non-pharmacologic strategies may be better suited to your health profile and goals
Mechanistic Comparison# Dosing Comparison# Amycretin Dosing# Amycretin dosing is investigational: Subcutaneous: Once-weekly injection, doses up to 60 mg studied in phase 1b/2a over 36 weeks Oral: Daily tablet, doses up to 50 mg (or 2 x 50 mg) studied in phase 1 Phase 2 T2D: Both subcutaneous and oral formulations studied over 36 weeks Phase 3 dose selection will be informed by the completed phase 2 data
A well-functioning anus contributes to a healthy gut microbiome, as the timely expulsion of stool prevents the buildup of harmful bacteria
